Table 2. Use of antihypertensive medications.
| Patients with hypertension (%) | Uncontrolled | Controlled | |
|---|---|---|---|
| Antihypertensive Medication | |||
| Yes | 4858 (97.4) | 2402 (95.0) | 2456 (100.0) |
| No | 127 (2.6) | 127 (5.0) | 0 (0.0) |
| Antihypertensive medication sorted by substance class | |||
| RAS inhibitors (total) | 4134 (82.9) | 2026 (80.1) | 2108 (85.9) |
| ACE inhibitors | 2439 (48.9) | 1140 (45.1) | 1299 (52.9) |
| Angiotensin receptor blocker | 2011 (40.3) | 1031 (40.8) | 980 (39.9) |
| Renin inhibitors | 285 (5.7) | 176 (6.9) | 109 (4.4) |
| Combined RAS blockade (total) | 585 (11.7) | 313 (12.4) | 272 (11.1) |
| ACEI and ARB | 396 (7.9) | 197 (7.8) | 199 (8.1) |
| ACEI and renin inhibitor | 84 (1.7) | 48 (1.9) | 36 (1.5) |
| ARB and renin inhibitor | 105 (2.1) | 68 (2.7) | 37 (1.5) |
| ACEI, ARB and renin inhibitor | 16 (0.3) | 8 (0.3) | 8 (0.3) |
| Beta blocker | 2844 (57.1) | 1474 (58.3) | 1370 (55.8) |
| Vasodilator | 219 (4.4) | 114 (4.5) | 105 (4.3) |
| Ca channel blocker | 1951 (39.1) | 1088 (43.0) | 863 (35.1) |
| Central Antiadrenergic | 627 (12.6) | 403 (15.9) | 224 (9.1) |
| Peripheral Antiadrenergic | 327 (6.6) | 215 (8.5) | 112 (4.6) |
| Diuretics (total) | 3119 (62.6) | 1546 (61.1) | 1573 (64.1) |
| Loop diuretic | 1988 (39.9) | 966 (38.2) | 1022 (41.6) |
| Thiazides and analogs | 1564 (31.4) | 803 (31.8) | 761 (30.1) |
| Potassium-sparing diuretics | 501 (10.1) | 200 (7.9) | 301 (12.3) |
Usage of a given drug class in percent was calculated in relation to all hypertensive patients, all hypertensive patients with uncontrolled blood pressure (≥140/90 mmHg), and all hypertensive patients with controlled blood pressure (<140/90 mmHg), respectively. RAS, renin-angiotensin system. ACEI, angiotensin converting enzyme inhibitors. ARB, angiotensin receptor blockers. RI, renin inhibitor. Ca, Calcium.